Sugi Predict

Sugi Predict / Compounds / SCHEMBL20799366

SCHEMBL20799366

SCHEMBL20799366

CCC(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNCN)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CS)C(N)=O

nearest known ligand 0.49

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ NPY4R P50391 18/20 0.49
▸ NPY5R Q15761 10/20 0.49
▸ NPY1R P25929 10/20 0.49
▸ NPY2R P49146 7/20 0.49
▸ TLR2 O60603 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17849796 0.93 NPY4R (0.53) NPY4RNPY5RNPY1RNPY2RTLR2
SCHEMBL17350018 0.93 NPY4R (0.53) NPY4RNPY5RNPY1RNPY2RTLR2
SCHEMBL17849843 0.87 NPY4R (0.51) NPY4RNPY5RNPY1RNPY2RTLR2
SCHEMBL18264812 0.82 NPY4R (0.46) NPY4RNPY5RNPY1RNPY2R
SCHEMBL19696558 0.82 NPY4R (0.55) NPY4RNPY5RNPY1RNPY2RTLR2
SCHEMBL17350014 0.81 NPY4R (0.44) NPY4RNPY5RNPY1RNPY2R
SCHEMBL22791266 0.81 SIRT5 (0.50) NPY4RNPY5RNPY1RNPY2R
SCHEMBL18264843 0.81 SIRT5 (0.50) NPY4RNPY5RNPY1RNPY2R
SCHEMBL16421648 0.81 NPY4R (0.45) NPY4RNPY5RNPY1RNPY2R
SCHEMBL12417527 0.81 MEN1 (0.45) NPY4RNPY5RNPY1RNPY2RTLR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10226539-B2 Selective delivery molecules and methods of use AVELAS BIOSCIENCES, INC. (US) 2019-03-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10226539-B2 Selective delivery molecules and methods of use SLC2A8, CD44, SLC2A3 NPY4R 836/4885NPY5R 2037/4885NPY1R 741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.